Angiotensin-converting enzyme insertion/deletion polymorphism and systemic lupus erythematosus: A metaanalysis

Journal of Rheumatology

Volumn 33, Issue 4, 2006, Pages 698-702

  Lee, Young Ho ^a,b   Rho, Young Hee ^a   Choi, Seong Jae ^a   Ji, Jong Dae ^a   Song, Gwan Gyu ^a  

^a Korea University College of Medicine   (South Korea)

^b Korea University Ansan Hospital   (South Korea)

Author keywords

Angiotensin converting enzyme; Metaanalysis; Polymorphisms; Systemic lupus erythematosus

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE;

ALLELE; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DNA POLYMORPHISM; ETHNOLOGY; GENE; GENE DELETION; GENE INSERTION; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; GENOTYPE; HUMAN; INTRON; LUPUS ERYTHEMATOSUS; MEDLINE; META ANALYSIS; PRIORITY JOURNAL; SYSTEMATIC REVIEW; SYSTEMIC LUPUS ERYTHEMATOSUS;

ADULT; FEMALE; GENE DELETION; GENETIC PREDISPOSITION TO DISEASE; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MEDLINE; MIDDLE AGED; MUTAGENESIS, INSERTIONAL; ODDS RATIO; PEPTIDYL-DIPEPTIDASE A; POLYMORPHISM, GENETIC;

EID: 33645835498     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Boumpas DT, Fessler BJ, Austin HA III, Balow JE, Klippel JH, Lockshin MD. Systemic lupus erythematosus: emerging concepts. Part 2: Dermatologic and joint disease, the antiphospholipid antibody syndrome, pregnancy and hormonal therapy, morbidity and mortality, and pathogenesis. Ann Intern Med 1995;123:42-53.
2. Egido J. Vasoactive hormones and renal sclerosis. Kidney Int 1996;49:578-97.
3. Weinstock JV, Blum AM, Kassab JT. Angiotensin II is chemotactic for a T-cell subset which can express migration inhibition factor activity in murine schistosomiasis mansoni. Cell Immunol 1987;107:180-7.
4. Rigat B, Hubert C, Alhene-Gelas F, Cambien F, Corvol P, Soubrier F. An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels. J Clin Invest 1990;86:1343-6.
5. Saeed M, Mekan SF, Rabbani MA, Arain FM, Arif M, Shaharyar S. Angiotensin converting enzyme (ACE) gene polymorphisms and lupus disease severity: a promising link. Ann Rheum Dis 2005;64:164-5.
6. Douglas G, Reilly C, Dooley MA, Page G, Cooper G, Gilkeson G. Angiotensin-converting enzyme (insertion/deletion) and endothelial nitric oxide synthase polymorphisms in patients with systemic lupus erythematosus. J Rheumatol 2004;31:1756-62.
7. Uhm WS, Lee HS, Chung YH, et al. Angiotensin-converting enzyme gene polymorphism and vascular manifestations in Korean patients with SLE. Lupus 2002;11:227-33.
8. Prkacin I, Novak B, Sertiec J, Mrzljak A. Angiotensin-converting enzyme gene polymorphism in patients with systemic lupus. Acta Med Croatica 2001;55:73-6.
9. Kaufman KM, Kelly J, Gray-McGuire C, et al. Linkage analysis of angiotensin-converting enzyme (ACE) insertion/deletion polymorphism and systemic lupus erythematosus. Mol Cell Endocrinol 2001;177:81-5.
10. Molad Y, Gal E, Magal N, et al. Renal outcome and vascular morbidity in systemic lupus erythematosus (SLE): lack of association with the angiotensin-converting enzyme gene polymorphism. Semin Arthritis Rheum 2000;30:132-7.
11. Pullmann R Jr, Lukac J, Skerenova M, et al. Association between systemic lupus erythematosus and insertion/deletion polymorphism of the angiotensin converting enzyme (ACE) gene. Clin Exp Rheumatol 1999;17:593-6.
12. Guan T, Liu Z, Chen Z. Angiotensin-converting enzyme gene polymorphism and the clinical pathological features and progression in lupus nephritis. Zhonghua Nei Ke Za Zhi 1997;36:461-4.
13. Akai Y, Sato H, Iwano M, et al. Association of an insertion polymorphism of angiotensin-converting enzyme gene with the activity of lupus nephritis. Clin Nephrol 1999;51:141-6.
14. Tassiulas IO, Aksentijevich I, Salmon JE, Kim Y, et al. Angiotensin I converting enzyme gene polymorphisms in systemic lupus erythematosus: decreased prevalence of DD genotype in African American patients. Clin Nephrol 1998;50:8-13.
15. Egger M, Smith GD, Phillips AN. Meta-analysis: principles and procedures. BMJ 1997;315:1533-7.
16. In. Egger M, Davey SG, Schneider M, Minder C. Bias in metal-analysis detected by a simple, graphical test. BMJ 1997;315:629-34.
17. Davey Smith G, Egger M. Meta-analyses of randomised controlled trials [letter]. Lancet 1997;350:1182.
18. Higgins JP, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med 2002;21:1539-58.
19. Yusuf S, Peto R, Lewis J, Collins R, Sleight P. Beta blockade during and after myocardial infarction: an overview of the randomized trials. Prog Cardiovasc Dis 1985;27:335-71.
20. DerSimoniun R, Laird N. Meta-analysis in clinical trials. Control Clin Trials 1986;7:177-88.
21. Parsa A, Peden E, Lum RF, et al. Association of angiotensin-converting enzyme polymorphisms with systemic lupus erythematosus and nephritis: analysis of 644 SLE families. Genes Immun 2002;3:542-6.
22. Sato H, Akai Y, Iwano M, et al. Association of an insertion polymorphism of angiotensin-converting enzyme gene with the activity of systemic lupus erythematosus. Lupus 1998;7:530-4.
23. Elkins JS, Douglas VC, Johnston SC. Alzheimer disease risk and genetic variation in ACE: a meta-analysis. Neurology 2004;62:363-8.
24. Qu H, Lu Y, Lin S. Meta-analysis on the association of ACE/ID polymorphism and essential hypertension in Chinese population. Zhonghua Yu Fang Yi Xue Za Zhi 2001;35:408-11.
25. Fujisawa T, Ikegami H, Kawaguchi Y, et al. Meta-analysis of association of insertion/deletion polymorphism of angiotensin I-converting enzyme gene with diabetic nephropathy and retinopathy. Diabetologia 1998;41:47-53.
26. Sharma P. Meta-analysis of the ACE gene in ischaemic stroke. J Neurol Neurosurg Psychiatry 1998;64:227-30.
27. Samani NJ, Thompson JR, O'Toole L, Channer K, Woods KL. A meta-analysis of the association of the deletion allele of the angiotensin-converting enzyme gene with myocardial infarction. Circulation 1996;94:708-12.